ArticleCureus2026
Herpes Zoster of the Larynx: A Diagnostic and Therapeutic Challenge.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Herpes zoster of the larynx is an exceptionally rare condition that may mimic more common causes of laryngitis. Reactivation of varicella-zoster virus in the vagus nerve can lead to odynophagia, dysphonia, and dysphagia, often without the typical cutaneous rash. Early recognition is essential, as delayed diagnosis may result in serious complications, including postherpetic neuralgia, persistent dysphagia, chronic voice impairment, and even laryngeal paralysis. We describe a 66-year-old woman on long-term low-dose corticosteroid therapy who presented with acute odynophagia, dysphagia, dysphonia, and fever. Flexible nasopharyngolaryngoscopy revealed supraglottic vesicles localized to the right hemilarynx, extending to the epiglottis and arytenoid region, with ipsilateral sensory loss. Serological testing confirmed varicella-zoster virus infection. The patient was treated with valacyclovir and gabapentin, with resolution of odynophagia and mucosal lesions at one month, though mild dysphagia persisted. Laryngeal herpes zoster represents a diagnostic challenge due to its rarity, overlapping symptoms with other forms of laryngitis, and the brief window of opportunity in which vesicular lesions are visible. The scarcity of reported cases underscores the importance of maintaining a high index of suspicion, particularly in immunosuppressed patients. Early antiviral therapy is crucial to reduce complications, while endoscopic evaluation plays a key role in timely recognition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.